OLUSHOLA OLORUNNIPA

Concepts (59)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prone Position
1
2021
32
0.690
Why?
Facial Injuries
1
2021
23
0.690
Why?
Patient Positioning
1
2021
51
0.670
Why?
Pressure Ulcer
1
2021
70
0.670
Why?
Mammaplasty
2
2020
44
0.250
Why?
Dentition
1
2021
5
0.180
Why?
Mastectomy, Subcutaneous
1
2020
2
0.160
Why?
Nipples
1
2020
8
0.160
Why?
Perforator Flap
1
2020
8
0.160
Why?
Respiration, Artificial
1
2021
503
0.140
Why?
Endoscopy
1
2018
272
0.120
Why?
Craniosynostoses
1
2018
157
0.120
Why?
Breast Neoplasms
2
2020
2648
0.110
Why?
Granular Cell Tumor
1
2014
3
0.110
Why?
Thoracic Wall
1
2014
41
0.100
Why?
Mastectomy
1
2013
75
0.100
Why?
Angiography
1
2013
187
0.100
Why?
Surgical Flaps
1
2013
182
0.090
Why?
Skin
1
2013
547
0.080
Why?
Ischemia
1
2013
355
0.080
Why?
HIV-2
1
2006
8
0.060
Why?
Gene Products, tat
1
2006
27
0.060
Why?
HIV Antibodies
1
2006
69
0.060
Why?
Aged
2
2021
20972
0.050
Why?
Esthetics
1
2020
40
0.040
Why?
Humans
6
2021
130857
0.030
Why?
Blood Loss, Surgical
1
2018
169
0.030
Why?
Patient Satisfaction
1
2020
453
0.030
Why?
Male
1
2021
64722
0.030
Why?
HIV Infections
1
2006
2015
0.030
Why?
Mastectomy, Segmental
1
2014
39
0.030
Why?
Middle Aged
4
2020
28513
0.030
Why?
Sentinel Lymph Node Biopsy
1
2014
69
0.030
Why?
Coloring Agents
1
2013
71
0.030
Why?
Carcinoma, Ductal, Breast
1
2014
87
0.030
Why?
Indocyanine Green
1
2013
54
0.030
Why?
Lasers
1
2013
113
0.020
Why?
Incidental Findings
1
2014
125
0.020
Why?
Necrosis
1
2013
194
0.020
Why?
Lymph Node Excision
1
2014
164
0.020
Why?
Intraoperative Care
1
2013
121
0.020
Why?
Length of Stay
1
2018
1398
0.020
Why?
Neoplasm Invasiveness
1
2014
632
0.020
Why?
Retrospective Studies
2
2020
17684
0.020
Why?
Adult
3
2020
31275
0.020
Why?
Female
4
2020
70681
0.020
Why?
tat Gene Products, Human Immunodeficiency Virus
1
2006
32
0.020
Why?
Postoperative Complications
1
2018
3115
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
2006
783
0.010
Why?
United States
1
2020
11838
0.010
Why?
Immunoglobulin G
1
2006
790
0.010
Why?
Prospective Studies
1
2013
6495
0.010
Why?
Survival Analysis
1
2006
1512
0.010
Why?
Infant
1
2018
13330
0.010
Why?
Treatment Outcome
1
2018
12915
0.010
Why?
Longitudinal Studies
1
2006
1503
0.010
Why?
Disease Progression
1
2006
2204
0.010
Why?
Time Factors
1
2006
6242
0.010
Why?
Risk Factors
1
2006
11004
0.010
Why?
OLORUNNIPA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (59)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_